highperformr logo

Cybrexa Therapeutics's Overview

Total employees17
HeadquartersNew Haven
Founded2017

Cybrexa Therapeutics is a clinical-stage biotechnology company at the forefront of developing a new class of cancer therapeutics. Leveraging its proprietary alphalex™ technology platform, Cybrexa aims to deliver powerful anti-cancer agents directly and preferentially to tumor cells, thereby minimizing systemic toxicity and enhancing treatment efficacy. The company's pipeline focuses on addressing unmet needs in various oncology indications, with lead candidates progressing through clinical development. Their innovative approach seeks to revolutionize how cancer is treated by improving the therapeutic window of potent cytotoxics.

Where is Cybrexa Therapeutics's Headquarters?

HQ Function

The New Haven headquarters serves as the central node for Cybrexa's research and development, clinical trial management, strategic partnerships, and corporate operations.

Notable Features:

Situated within New Haven's Science Park area, the headquarters benefits from proximity to leading academic institutions and a strong biotech ecosystem, fostering collaboration and access to talent.

Work Culture:

The work culture at Cybrexa Therapeutics is characterized by a strong scientific focus, innovation, collaboration, and a patient-centric mission to develop impactful cancer therapies. Employees often describe it as dynamic and driven.

HQ Significance:

Its location in New Haven is significant for access to world-class research facilities, a skilled talent pool from institutions like Yale, and a supportive environment for biotech startups and clinical-stage companies.

Values Reflected in HQ: The headquarters' location and setup reflect Cybrexa's commitment to scientific excellence, innovation, and collaboration within the broader biomedical community.

Location:

As a clinical-stage company, Cybrexa Therapeutics's global presence is primarily established through its clinical trial sites, which may be located across North America, Europe, and other regions, in collaboration with leading cancer research centers and hospitals. They also engage with the global scientific and investment community through conferences and partnerships.

Street Address:

55 Church Street, 8th Floor

City:

New Haven

State/Province:

CT

Country:

USA

Cybrexa Therapeutics's Global Presence

Buying Intent Signals for Cybrexa Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cybrexa Therapeutics

As of April 2025, Cybrexa Therapeutics' leadership includes:

Per Hellsund - President & Chief Executive Officer
Vishwas S. Paralkar, Ph.D. - Chief Scientific Officer
Michael Needle, M.D. - Chief Medical Officer
Sebastian Guth, Ph.D. - Chief Business Officer
Arthur Hiller, Ph.D. - SVP, Chief Technical Operations Officer

Investors of Cybrexa Therapeutics

Cybrexa Therapeutics has been backed by several prominent investors over the years, including:

HighCape Capital
Connecticut Innovations
Elm Street Ventures
CMax Group

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Over the past year, Cybrexa Therapeutics has focused on strengthening its leadership team to guide its clinical development programs and strategic growth. Notably, the company appointed a new Chief Business Officer.

New Appointments:

Sebastian Guth, PhD, Dr. Sebastian Guth joined Cybrexa Therapeutics as Chief Business Officer to lead the company's business development activities, strategic partnerships, and commercial planning.

Technology (Tech Stack) used by Cybrexa Therapeutics

Discover the tools Cybrexa Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cybrexa Therapeutics Email Formats and Examples

Cybrexa Therapeutics likely utilizes common corporate email formats. The most probable structure is [firstinitial][last]@cybrexa.com. For official communication, it is always recommended to use the contact forms or general inquiry emails provided on their official website.

flast@cybrexa.com

Format

phellsund@cybrexa.com

Example

80%

Success rate

News and media

Cybrexa Therapeutics Press ReleaseApril 8, 2024

Cybrexa Therapeutics Presents Preclinical Data on CBX-15 (alphalex™-Exatecan) at the American Association for Cancer Research (AACR) Annual Meeting 2024

Cybrexa Therapeutics announced the presentation of preclinical data on its novel alphalex™-exatecan conjugate, CBX-15, at the AACR Annual Meeting 2024. The data highlighted CBX-15's superior tumor cell penetration and DNA damage response, suggesting its potential as a treatment for various solid tumors....more

Cybrexa Therapeutics Press ReleaseOctober 10, 2023

Cybrexa Therapeutics Receives FDA Fast Track Designation for CBX-12 (alphalex™-Exatecan) for the Treatment of Metastatic Small Cell Lung Cancer

The U.S. Food and Drug Administration (FDA) granted Fast Track designation to CBX-12 for the treatment of patients with metastatic small cell lung cancer (SCLC) who have progressed following two prior lines of therapy. This designation aims to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need....more

Cybrexa Therapeutics Press ReleaseMay 2, 2023

Cybrexa Therapeutics Appoints Dr. Sebastian Guth as Chief Business Officer

Cybrexa Therapeutics announced the appointment of Sebastian Guth, Ph.D., as Chief Business Officer. Dr. Guth brings over 20 years of experience in the biopharmaceutical industry, with a strong background in business development, commercialization, and corporate strategy....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cybrexa Therapeutics, are just a search away.